Pfizer says its COVID vaccine is highly effective in kids ages 5-11: Here’s the latest

Pfizer’s COVID-19 vaccine had a 90.7% efficacy rate in preventing symptomatic COVID-19 with symptoms in kids ages 5-11, according to data on a clinical trial the drug-maker submitted to the US Food and Drug Administration. The FDA is expected to authorize Pfizer’s vaccine for kids as young as 5 years old following an evaluation by its independent advisory committee next week.

On Wednesday, the White House shared a plan to get kids under 12 vaccinated against the coronavirus, saying it “will be ready to begin getting shots in arms in the days following a final CDC recommendation.” Pfizer’s COVID-19 vaccine is expected to be authorized first, and recommended for kids ages 5-11 in early November. (Children 12 and over are already eligible for the Pfizer, Moderna and Johnson & Johnson vaccines.)

When and if the COVID-19 vaccine for kids 5-11 is authorized, don’t expect the same vaccine campaign and mass vaccination sites that were used to reach adults. According to the Biden administration, efforts and resources will be channeled to pharmacies, doctor’s offices, children’s hospitals and school- and community-based centers. In other words, there may be a more personal approach. (As the New York Times reported, lines of crying kids at mass vaccination sites are best avoided, as children may not love the idea of receiving a shot in the first place.) Like all COVID-19 vaccines, shots for kids will be free.

The COVID-19 vaccine shot itself may also look different for younger kids. Children ages 5-11 will be receiving a smaller dose of Pfizer’s vaccine — 10 micrograms instead of the 30 micrograms given to people age 12 and older — and it will be administered through a smaller needle…Read more>>


Register Form

Email Address
Phone No